Skip to main content
All lobbying clients

IRA WATCHDOG

Lobbying client · District of Columbia · filed 2025 to 2026

Coalition analyzing impact of Medicare Drug Price Negotiation on patients.

$120,000 Reported spend
6 Filings counted
1 Firms hired
0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (68339), not by name.

 Firms hired 1
 Reported by year 2 years
  • 2026 $60,000 2 filings
  • 2025 $60,000 4 filings
 Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 2
  • HOUSE OF REPRESENTATIVES 5
  • SENATE 5
 Foreign entities disclosed 1
  • ASTRAZENECA PLC United Kingdom named on 1 filing · highest disclosed ownership 0% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

 Affiliated organisations 4
  • ASTRAZENECA PHARMACEUTICALS LP United States of America named on 1 filing
  • BRISTOL-MYERS SQUIBB COMPANY United States of America named on 1 filing
  • ELI LILLY AND COMPANY United States of America named on 1 filing
  • MERCK & CO., INC. United States of America named on 1 filing

Section 6 of the LD-2: organisations that contribute to or take part in this client's lobbying.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem